Clutching At Straws? – Yext, Inc. (YEXT), Guardion Health Sciences, Inc. (GHSI)

  • Summary:


    The stocks of Yext, Inc. (NYSE:YEXT) has been Reiterated as a Underweight by Morgan Stanley in its latest research note that was published on October 16. YEXT was given a price target of $15 by Morgan Stanley, with other Wall Street analysts also giving their reports regarding the stock. The stock also received a Equal-Weight to Underweight rating from Morgan Stanley. This was contained in a research note published by the firm on January 15. The stock received a Buy rating and a price target of $25 in Berenberg’s research note that was published on November 16.

    Yext,’s stock is covered by 7 analysts, with 5 of them rating the stock as Buy. It has been deemed to have strong buy by none of the analysts, 1 of them have rated it as a Hold while 1 of them rated it as sell. Meanwhile, none an ...



    Read Full News:

Log in to reply